Trials / Recruiting
RecruitingNCT01000883
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from women with locally advanced or metastatic breast cancer
Detailed description
OBJECTIVES: * Collect , catalogue, and store biological specimens from patients with locally advanced or metastatic breast cancer * To collect clinical data from these patients containing identifiers, demographics, epidemiologic review, clinical evaluation, treatment, and long-term follow-up. * To provide an efficient bi-directional flow of clinical information and specimens between laboratory and clinical scientists in order to foster innovative translational research. OUTLINE: This is a multicenter study. Patients undergo core biopsy and blood sampling at diagnosis, between chemotherapy regimens, and prior to definitive surgery. Tumor markers are assessed using immunohistochemistry and flow cytometry. PROJECTED ACCRUAL: A total of 500 patients will be accrued for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | biologic sample preservation procedure | approximately 16-20 milligrams of tumor tissue per core will be obtained for research purposes. |
| OTHER | laboratory biomarker analysis | Evaluation of biomarkers will occur as questions are asked in subsequent correlative studies. |
| PROCEDURE | biopsy | cancer tissue will be taken from the primary breast cancer site as well as the metastatic tumor sites. Two tubes of whole blood will also be collected. |
Timeline
- Start date
- 1998-12-01
- Primary completion
- 2030-11-01
- Completion
- 2032-11-01
- First posted
- 2009-10-23
- Last updated
- 2025-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01000883. Inclusion in this directory is not an endorsement.